Related references
Note: Only part of the references are listed.B-cell depletion and remissions of malignancy along with cytokine-associated toxicity in a clinical trial of anti-CD19 chimeric-antigen-receptor-transduced T cells
James N. Kochenderfer et al.
BLOOD (2012)
Editing T cell specificity towards leukemia by zinc finger nucleases and lentiviral gene transfer
Elena Provasi et al.
NATURE MEDICINE (2012)
Safety and persistence of adoptively transferred autologous CD19-targeted T cells in patients with relapsed or chemotherapy refractory B-cell leukemias
Renier J. Brentjens et al.
BLOOD (2011)
Mutation in the TCRα subunit constant gene (TRAC) leads to a human immunodeficiency disorder characterized by a lack of TCRαβ+ T cells
Neil V. Morgan et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
CD28 costimulation improves expansion and persistence of chimeric antigen receptor-modified T cells in lymphoma patients
Barbara Savoldo et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
CARs on Track in the Clinic
Donald B. Kohn et al.
MOLECULAR THERAPY (2011)
Chimeric Antigen Receptor-Modified T Cells in Chronic Lymphoid Leukemia
David L. Porter et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Establishment of Antitumor Memory in Humans Using in Vitro-Educated CD8+ T Cells
Marcus O. Butler et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
T Cells with Chimeric Antigen Receptors Have Potent Antitumor Effects and Can Establish Memory in Patients with Advanced Leukemia
Michael Kalos et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Translating Sleeping Beauty transposition into cellular therapies: Victories and challenges
Zsuzsanna Izsvak et al.
BIOESSAYS (2010)
Successful treatment of EBV-associated posttransplantation lymphoma after cord blood transplantation using third-party EBV-specific cytotoxic T lymphocytes
Juliet N. Barker et al.
BLOOD (2010)
Eradication of B-lineage cells and regression of lymphoma in a patient treated with autologous T cells genetically engineered to recognize CD19
James N. Kochenderfer et al.
BLOOD (2010)
Allo-HLA reactivity of virus-specific memory T cells is common
Avital L. Amir et al.
BLOOD (2010)
Redirecting T-cell specificity by introducing a tumor-specific chimeric antigen receptor
Bipulendu Jena et al.
BLOOD (2010)
Combining CD19 Redirection and Alloanergization to Generate Tumor-Specific Human T Cells for Allogeneic Cell Therapy of B-Cell Malignancies
Jeff K. Davies et al.
CANCER RESEARCH (2010)
piggyBac Transposon/Transposase System to Generate CD19-Specific T Cells for the Treatment of B-Lineage Malignancies
Pallavi V. Raja Manuri et al.
HUMAN GENE THERAPY (2010)
The Optimal Antigen Response of Chimeric Antigen Receptors Harboring the CD3ζ Transmembrane Domain Is Dependent upon Incorporation of the Receptor into the Endogenous TCR/CD3 Complex
John S. Bridgeman et al.
JOURNAL OF IMMUNOLOGY (2010)
A Transposon and Transposase System for Human Application
Perry B. Hackett et al.
MOLECULAR THERAPY (2010)
Human hematopoietic stem/progenitor cells modified by zinc-finger nucleases targeted to CCR5 control HIV-1 in vivo
Nathalia Holt et al.
NATURE BIOTECHNOLOGY (2010)
Transient cold shock enhances zinc-finger nuclease-mediated gene disruption
Yannick Doyon et al.
NATURE METHODS (2010)
Genome editing with engineered zinc finger nucleases
Fyodor D. Urnov et al.
NATURE REVIEWS GENETICS (2010)
Improved Expression and Reactivity of Transduced Tumor-Specific TCRs in Human Lymphocytes by Specific Silencing of Endogenous TCR
Sachiko Okamoto et al.
CANCER RESEARCH (2009)
Redirecting specificity of T-cell Populations for CD19 using the Sleeping beauty system
Harjeet Singh et al.
CANCER RESEARCH (2008)
Sleeping Beauty vector system moves toward human trials in the United States
David A. Williams
MOLECULAR THERAPY (2008)
Establishment of HIV-1 resistance in CD4+ T cells by genome editing using zinc-finger nucleases
Elena E. Perez et al.
NATURE BIOTECHNOLOGY (2008)
Heritable targeted gene disruption in zebrafish using designed zinc-finger nucleases
Yannick Doyon et al.
NATURE BIOTECHNOLOGY (2008)
Virus-specific T cells engineered to coexpress tumor-specific receptors: persistence and antitumor activity in individuals with neuroblastoma
Martin A. Pule et al.
NATURE MEDICINE (2008)
Targeted gene knockout in mammalian cells by using engineered zinc-finger nucleases
Yolanda Santiago et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Antigen-independent and antigen-dependent methods to numerically expand CD19-specific CD8+ T cells
Tontanai Numbenjapon et al.
EXPERIMENTAL HEMATOLOGY (2007)
Engineered human tmpk/AZT as a novel enzyme/prodrug axis for suicide gene therapy
Takeya Sato et al.
MOLECULAR THERAPY (2007)
Targeting the activation-induced antigen CD137 can selectively deplete alloreactive T cells from antileukemic and antitumor donor T-cell lines
Thomas C. Wehler et al.
BLOOD (2007)
CD28 costimulation provided through a CD19-specific chimeric antigen receptor enhances in vivo persistence and antitumor efficacy of adoptively transferred T cells
Claudia M. Kowolik et al.
CANCER RESEARCH (2006)
Depletion of alloreactive T cells via CD69: implications on antiviral, antileukemic and immunoregulatory T lymphocytes
UF Hartwig et al.
BONE MARROW TRANSPLANTATION (2006)
An inducible caspase 9 safety switch for T-cell therapy
KC Straathof et al.
BLOOD (2005)
Enhanced antilymphoma efficacy of CD19-redirected influenza MP1-specific CTLs by cotransfer of T cells modified to present influenza MP1
LJN Cooper et al.
BLOOD (2005)
Pharmacologically regulated Fas-mediated death of adoptively transferred T cells in a nonhuman primate model
C Berger et al.
BLOOD (2004)
Transfer of aflogeneic CD62L- memory T cells without graft-versus-host disease
BJ Chen et al.
BLOOD (2004)
Development and application of CD19-specific T cells for adoptive immunotherapy of B cell malignancies
LJN Cooper et al.
BLOOD CELLS MOLECULES AND DISEASES (2004)
Central memory and effector memory T cell subsets: Function, generation, and maintenance
F Sallusto et al.
ANNUAL REVIEW OF IMMUNOLOGY (2004)
Human CD62L- memory T cells are less responsive to alloantigen stimulation than CD62L+ naive T cells:: potential for adoptive immunotherapy and allodepletion
AE Foster et al.
BLOOD (2004)
Molecules and mechanisms of the graft-versus-leukaemia effect
M Bleakley et al.
NATURE REVIEWS CANCER (2004)
Selective depletion of donor alloreactive T cells without loss of antiviral or antileukernic responses
PJ Amrolia et al.
BLOOD (2003)
Treatment of Epstein-Barr-virus-positive post-transplantation lymphoproliferative disease with partly HLA-matched allogeneic cytotoxic T cells
T Haque et al.
LANCET (2002)
Human T-lymphocyte cytotoxicity and proliferation directed by a single chimeric TCR zeta/CD28 receptor
J Maher et al.
NATURE BIOTECHNOLOGY (2002)
Genetic modification of human T cells with CD20: A strategy to purify and lyse transduced cells with anti-CD20 antibodies
M Introna et al.
HUMAN GENE THERAPY (2000)
Share Paper
